World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
75
Citations
29975
World Ranking
5213
National Ranking
339

Overview

Robert Lanza is affiliated with Astellas Pharma (Japan) and conducts research primarily in the fields of Biochemistry, Genetics, and Molecular Biology, as well as Medicine. Their subfields of study include Molecular Biology, Genetics, Radiology, Nuclear Medicine and Imaging, Public Health, Environmental and Occupational Health, and Biomedical Engineering.

Their research covers a range of topics, notably:

  • CRISPR and Genetic Engineering
  • Pluripotent Stem Cells Research
  • Virus-based gene therapy research
  • Corneal Surgery and Treatments
  • Ocular Surface and Contact Lens
  • Corneal surgery and disorders
  • 3D Printing in Biomedical Research

Lanza has published in various scientific venues, with frequent publications in:

  • Nature Reviews Drug Discovery
  • Stem Cell Reports
  • Frontiers in Medicine

Some of their recent papers include:

  • Next-generation stem cells - ushering in a new era of cell-based therapies (2020, Nature Reviews Drug Discovery)
  • Human ESC-Derived MSCs Outperform Bone Marrow MSCs in the Treatment of an EAE Model of Multiple Sclerosis (2021, Stem Cell Reports)
  • Human Hemangioblast-Derived Mesenchymal Stem Cells Promote Islet Engraftment in a Minimal Islet Mass Transplantation Model in Mice (2021, Frontiers in Medicine)

Robert Lanza collaborates with multiple co-authors regularly, including:

  • Erin A. Kimbrel
  • Xiaofang Wang
  • Kumiko Ijichi
  • Debayon Paul
  • Adam S. Lazorchak

Best Publications

  • Principles of tissue engineering

    Robert Lanza;Robert Langer;Joseph Vacanti.

  • Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins.

    Dohoon Kim;Chun-Hyung Kim;Jung-Il Moon;Young-Gie Chung

  • Embryonic stem cell trials for macular degeneration: a preliminary report

    Steven D Schwartz;Jean-Pierre Hubschman;Gad Heilwell;Valentina Franco-Cardenas

  • Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies

    Steven D. Schwartz;Carl D. Regillo;Byron L. Lam;Dean Eliott

  • Human embryonic stem cell lines derived from single blastomeres

    Irina Klimanskaya;Young Chung;Sandy Becker;Shi-Jiang Lu

  • Extension of Cell Life-Span and Telomere Length in Animals Cloned from Senescent Somatic Cells

    Robert P. Lanza;Jose B. Cibelli;Catherine Blackwell;Vincent J. Cristofalo

  • Human Embryonic Stem Cell Lines Generated without Embryo Destruction

    Young Chung;Irina Klimanskaya;Sandy Becker;Tong Li

  • Long‐Term Safety and Function of RPE from Human Embryonic Stem Cells in Preclinical Models of Macular Degeneration

    Bin Lu;Christopher Malcuit;Shaomei Wang;Sergej Girman

  • 'Insight' in the pigeon: antecedents and determinants of an intelligent performance.

    R. Epstein;C. E. Kirshnit;R. P. Lanza;L. C. Rubin

  • Restoration of normal morphology, adhesion and cytoskeleton in transformed cells by addition of a transformation-sensitive surface protein

    Iqbal Unnisa Ali;Vivien Mautner;Robert Lanza;Richard O. Hynes

  • Cloning of an endangered species (Bos gaurus) using interspecies nuclear transfer.

    Robert P. Lanza;Jose B. Cibelli;Francisca Diaz;Carlos T. Moraes

  • Human embryonic stem cells derived without feeder cells

    Irina Klimanskaya;Young Chung;Lorraine Meisner;Julie Johnson

  • Human Embryonic Stem Cell–Derived Cells Rescue Visual Function in Dystrophic RCS Rats

    Raymond D. Lund;Shaomei Wang;Irina Klimanskaya;Toby Holmes

  • Derivation and comparative assessment of retinal pigment epithelium from human embryonic stem cells using transcriptomics.

    Irina Klimanskaya;Jason Hipp;Kourous A. Rezai;Michael West

  • Parthenogenetic stem cells in nonhuman primates

    Jose B. Cibelli;Kathleen A. Grant;Karen B. Chapman;Kerrianne Cunniff

  • Embryonic and extraembryonic stem cell lines derived from single mouse blastomeres

    Young Chung;Irina Klimanskaya;Sandy Becker;Joel Marh

  • Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence.

    Qiang Feng;Shi‐Jiang Lu;Irina Klimanskaya;Ignatius Gomes

  • Treatment of Macular Degeneration Using Embryonic Stem Cell-Derived Retinal Pigment Epithelium: Preliminary Results in Asian Patients

    Won Kyung Song;Kyung-Mi Park;Hyun-Ju Kim;Jae Ho Lee

  • Generation of histocompatible tissues using nuclear transplantation

    Robert Lanza

  • Principles of Regenerative Medicine

    Anthony Atala;Robert Lanza;James A. Thomson;Robert M. Nerem

Frequent Co-Authors

Michael D. West
Michael D. West Advanced Cell Technology (United States)
Jose B. Cibelli
Jose B. Cibelli Michigan State University
Anthony Atala
Anthony Atala Wake Forest University
David K. C. Cooper
David K. C. Cooper University of Pittsburgh
Anthony P. Monaco
Anthony P. Monaco Tufts University
Michael West
Michael West Duke University
Nadia Rosenthal
Nadia Rosenthal National Institutes of Health
James J. Yoo
James J. Yoo Wake Forest University
S. S. Meyer
S. S. Meyer University of Chicago
Shay Soker
Shay Soker Wake Forest University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Robert Lanza

Trending Scientists

Recently Published Articles